FDA Expands ASCENIV Pediatric Use

• by Kathryn Wighton

• May 4, 2026

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

• by Mouj Hijazi

• October 28, 2026

• 2 min

Marked Increase in Diabetic Ketoacidosis Rates With Modest Increase in HbA1c Elevation at Diabetes Diagnosis in Swedish Children

• by Frida Sundberg, Katarina Eeg-Olofsson, Karin Åkesson

• September 17, 2026

FDA expands treatment in nephrotic syndrome

The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.

• by Kathryn Wighton

• September 28, 2026

• 2 min